pv-magazine-usa18m
OpenADR 3.0 standard can maximize demand flexibility to help integrate renewables
Berkeley Lab’s CalFlexHub says global adoption of an improved communications method can foster a transition from event-based ...
Intra-Cellular Therapies, Inc.: Intra-Cellular Therapies Settles CAPLYTA (lumateperone) Patent Litigation with Sandoz
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central ...
Barinthus Biotherapeutics: Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update
Prioritizing VTP-1000 development in celiac disease, Phase 1 data expected in mid-2025Postponing further clinical development of VTP-300 in chronic hepatitis B (CHB) until a partner is identifiedExten ...